Interleukin-36 receptor antagonist deficiency patient with a novel mutation

Puntos clave

• Patients with interleukin-36 receptor antagonist deficiency experience severe inflammation.
• A novel mutation was identified, providing insights into the genetic basis of the condition.
• Case analysis reveals that interleukin-36 pathways are critical for immune response regulation.
• Understanding this mutation may lead to more targeted therapeutic strategies.